Debut Plus

31.7

-3.52 -9.99%

As of 11 Sept 2026 · delayed

NSE Listed · Realty

LT-ASM · ASM 1
What does LT-ASM · ASM 1 mean?
BSE · Long Term Additional Surveillance Measure (ASM 1)LT-ASM is the joint SEBI/exchange framework for SUSTAINED abnormal price moves (contrast ST-ASM's 5–15-day spikes). Entry is beta-adjusted price variation versus the Nifty (e.g. 3-month high-low above 150% plus the stock's β × index move) along with client-concentration checks. Stages I–IV escalate from a 5% price band through 100% margin to Trade-for-Trade with an additional surveillance deposit. Practical meaning: the exchange still considers the price action abnormal — tighter bands and elevated margins continue even if another measure (like ESM) has lifted. A stock can sit under LT-ASM on both exchanges via either exchange's shortlisting; it is a preventive cost-of-speculation measure, not an adverse finding against the company.Criteria: High 3-month / 12-month high-low price variation, close-to-close price variation, client concentration, number of price-band hits, market-wide position limit and P/E — applied in graded Stages I–IV with escalating margin and price-band curbs.Exchange notice · 2026-04-15

Medi-Caps Ltd. (MEDICAPQ)

Volume: 14,241Avg Vol 1W: 25,141Avg Vol 1M: 6,91152W Range:20.3336.8
Market Cap₹40 Cr
Current Price₹31.7
Previous Close₹35.22
High / Low (52w)₹36.8 / ₹20.33
Volume14,241
Avg Vol (1W)25,141
Avg Vol (1M)6,911
Stock P/E11.25
Book Value₹89.5
Dividend Yield0%
ROE-272.15%
ROA-154.17%
Revenue (TTM)
Revenue Growth
Profit Margin-14.31%
Total Debt
Shares Outstanding1 Cr
Face Value₹10
EPS (TTM)₹0
P/B0.35
Debt / Equity0
50 DMA₹26.65
200 DMA₹27.81
Day change-9.99%
SurveillanceLT-ASM · ASM 1
Price Chart
31.7 19.34% · 1Y
452263K
2025-09-11
2026-09-11

20-day avg volume: 7K shares

Pros
  • Company is almost debt-free.
  • Stock trades below its book value.
Cons
  • Revenue fell 81% YoY.
  • Company is loss-making at the latest annual result.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹8 Cr₹4 Cr₹7 Cr₹3 Cr₹2 Cr₹4 Cr₹3 Cr₹3 Cr
EBITDA₹0 Cr₹-2 Cr₹1 Cr₹-3 Cr₹-2 Cr₹-1 Cr₹3 Cr₹-2 Cr
Net Profit₹0 Cr₹-2 Cr₹2 Cr₹-3 Cr₹-2 Cr₹-1 Cr₹3 Cr₹-2 Cr
EPS
Profit & Loss (Annual)
MetricMar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026Jun 2026
Revenue₹28 Cr₹1 Cr₹0 Cr₹1 Cr₹1 Cr₹1 Cr₹21 Cr₹0 Cr
EBITDA₹-1 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹-3 Cr₹-1 Cr
Net Profit₹-1 Cr₹1 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹-3 Cr₹-1 Cr
EPS-0.46-2.44
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹107 Cr₹95 Cr₹115 Cr₹130 Cr₹126 Cr₹127 Cr₹125 Cr₹115 Cr
Total Liabilities₹11 Cr₹4 Cr₹10 Cr₹14 Cr₹7 Cr₹6 Cr₹4 Cr₹4 Cr
Equity₹96 Cr₹91 Cr₹105 Cr₹116 Cr₹119 Cr₹121 Cr₹121 Cr₹112 Cr
Total Debt
Cash Flow
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹6 Cr₹5 Cr₹15 Cr₹7 Cr₹-3 Cr₹8 Cr₹5 Cr₹-7 Cr
Investing₹-6 Cr₹-6 Cr₹-10 Cr₹-4 Cr₹-3 Cr₹-8 Cr₹-5 Cr₹7 Cr
Financing₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Free Cash Flow₹6 Cr₹5 Cr₹15 Cr₹7 Cr₹-3 Cr₹8 Cr₹5 Cr₹-7 Cr
Shareholding
Promoter 51.44% Institutions 0.02% Public 48.54%
Efficiency & Working Capital
ROCE-2.7%
Interest Coverage-534.9
Dividend Payout
Debtor Days203 d
Inventory Days86 d
Payable Days14 d
Cash Conversion Cycle275 d
Working Capital Days289 d
Shareholding Details

As of 2026-06-30

Promoter51.4%
FII0%
DII0%
Institutions0%
Public48.5%
Promoter Pledge0%
No. of Shareholders10,209
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters50.1%50.1%50.1%50.1%50.4%50.6%50.8%50.8%50.8%50.8%51.4%51.4%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public49.8%49.8%49.8%49.8%49.5%49.4%49.2%49.2%49.2%49.2%48.6%48.5%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders13,79013,22612,35611,73811,25511,17611,03310,85110,69210,49310,34910,209
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603
Major Shareholders (>1%)
NameCategoryStakeShares
Alok K GargShareholding of Promoter and Promoter Group26.3%32,74,866
Manisha GargShareholding of Promoter and Promoter Group21.6%26,94,820
Sangeetha SPublic Shareholding5.6%6,91,537
Dheeraj Kumar LohiaPublic Shareholding4.7%5,89,877
Trapti Investments LlpShareholding of Promoter and Promoter Group2.5%3,07,128
Sonal LohiaPublic Shareholding1.4%1,76,626
Manju GaggarPublic Shareholding1.1%1,37,520
Palash GargShareholding of Promoter and Promoter Group0.6%69,686
Akshit GargShareholding of Promoter and Promoter Group0.4%45,953
Kusum MittalShareholding of Promoter and Promoter Group0.1%12,000
Ramesh Chandra MittalShareholding of Promoter and Promoter Group0.1%10,000
Geetika AgrawalShareholding of Promoter and Promoter Group0%400
Nirmala MittalShareholding of Promoter and Promoter Group0%0
Board of Directors
NameDesignationYear
Alok K GargED / MD / Promoter2026
Ashok Omprakash AgrawalIndependent Non Exe. Director2026
Dharmendra SolankiIndependent Non Exe. Director2026
Gajendra SinghIndependent Non Exe. Director2026
Saloni GargWhole-time Director2026
ABHISHEK JAINCompany Sec. & Compli. Officer2026
Segments — Product
SegmentRevenueShare
Real Estate₹0 Cr
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹10151212
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-06Board Meetings
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2026000000
2026000000
2026000000
Substantial Acquisitions (SAST)

2 disclosure(s)

Market18/10/2023 - 09/07/2024 · 2,77,473
Market17/10/2023 · 41,387
Company Information
Incorporated1983
AuditorRawka & Associates
🌐 www.medicaps.com

📍 Mhow-Neemuch Road, Sector - I, Pithampur, Madhya Pradesh, 454775

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search